Zibo Qixiang Tengda Chemical (002408)

Search documents
齐翔腾达(002408) - 2016年9月6日投资者关系活动记录表
2022-12-06 01:38
证券代码:002408 证券简称:齐翔腾达 淄博齐翔腾达化工股份有限公司投资者关系活动记录表 编号:20161027 | --- | --- | --- | |-----------------------|-----------------------------|----------------------------------------------------| | | | | | 投资者关系活动 | ▇ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □其他 | (请文字说明其他活动内容) | | 参与单位名称及 | 中信证券 程威、黄哲 | | | 人员姓名 | | | | 时间 | 2016 年 9 月 6 日 | | | 地点 | 公司会议室 | | | 上市公司接待人 员姓名 | 周洪秀、姜能成 | | | 投资者关系活动 | 1 | 、控股股东的部分股东发生股权转让的动机? | | 主要内容介绍 | | 本次控股股东的部分股东发生股权转让事宜具体细节不便 | | | | ...
齐翔腾达(002408) - 齐翔腾达调研活动信息
2022-12-03 10:24
证券代码:002408 证券简称:齐翔腾达 淄博齐翔腾达化工股份有限公司投资者关系活动记录表 编号:20190419 | --- | --- | --- | |--------------|-------------------------|-----------------------------------------------------------| | | | | | 投资者关系 | ▇ | 特定对象调研 □分析师会议 | | 活动类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □其他 | (请文字说明其他活动内容) | | 参与单位名称 | | 海通证券 张璇 朱军军 天风证券 郑小兵 太平洋证券 柳强 招商 | | 及人员姓名 | | 证券 李舜 盘京投资 刘荣 国泰君安 肖洁 廖鹏飞 深圳金泊投资 | | | | 陈佳琦 光大证券 傅锴铭 中金公司 贾雄伟 长城证券 杨维维 东 | | | | 吴证券 陈立君 嘉实基金 付赫 国盛证券 李扬 常春藤资产 冯先 | | | | 涛 中信建投 于洋 财通证券 路辛之 ...
齐翔腾达(002408) - 2022 Q3 - 季度财报
2022-10-27 16:00
Financial Performance - The company's revenue for Q3 2022 was ¥6,873,242,466, a decrease of 14.15% compared to the same period last year[6]. - Net profit attributable to shareholders was ¥148,227,235.81, down 78.64% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥133,892,335.35, a decrease of 80.05%[6]. - The basic earnings per share for the quarter was ¥0.05, reflecting an 80.00% decline compared to the previous year[6]. - Total operating revenue for the current period is ¥23,278,380,523.33, a decrease of 9.2% from ¥25,755,541,024.23 in the previous period[23]. - Net profit for the current period is ¥1,039,249,455.58, a decline of 53.6% compared to ¥2,237,608,219.98 in the previous period[26]. - The total comprehensive income for the current period is ¥1,079,900,182.34, compared to ¥2,235,265,553.71 in the previous period, indicating a decrease of 51.7%[29]. Assets and Liabilities - Total assets increased to ¥28,556,481,638.61, representing a growth of 9.54% from the end of the previous year[6]. - The company's non-current assets totaled CNY 19.69 billion, an increase from CNY 17.11 billion, representing a growth of approximately 15.06%[20]. - The company's total liabilities increased to CNY 8.87 billion from CNY 7.96 billion, indicating a rise of about 11.43%[20]. - Total liabilities increased to ¥14,041,379,324.01 from ¥12,650,187,184.28, marking a growth of 10.9%[23]. - The company's total equity attributable to shareholders increased by 8.64% to ¥13,894,574,183.55 compared to the end of the previous year[6]. - Total equity attributable to shareholders of the parent company rose to ¥13,894,574,183.55 from ¥12,789,768,802.68, an increase of 8.7%[23]. Cash Flow - The company reported a net cash flow from operating activities of ¥1,353,262,895.03, which is a decrease of 11.19% year-to-date[6]. - The net cash flow from operating activities for the current period is CNY 1,353,262,895.03, a decrease of 11.15% compared to CNY 1,523,775,992.67 in the previous period[33]. - Total cash inflow from operating activities is CNY 25,193,244,413.87, down from CNY 25,996,353,360.49, reflecting a decline of 3.1%[33]. - Cash outflow from operating activities totaled CNY 23,839,981,518.84, compared to CNY 24,472,577,367.82 in the previous period, indicating a decrease of 2.6%[33]. - The net cash flow from investing activities is CNY -3,018,574,701.78, worsening from CNY -2,156,554,445.54 in the previous period[33]. - The net cash flow from financing activities increased to CNY 1,904,361,265.43, compared to CNY 927,367,373.15 in the previous period, showing an increase of 105.3%[33]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 78,474[12]. - The largest shareholder, Zibo Qixiang Petrochemical Group, holds 1,305,214,885 shares, accounting for 45.91% of the total shares[12]. - The second largest shareholder, Che Chengju, holds 105,027,091 shares, accounting for 3.69%[12]. - The top ten shareholders collectively hold a significant portion of the company's shares, with the largest three shareholders holding over 50%[12]. - The company has not disclosed any known relationships among the top ten shareholders, except for Che Chengju and Zibo Qixiang Petrochemical Group being acting in concert[12]. Investment and Financing Activities - A total of 2,990 million convertible bonds were issued, raising 2,990,000,000.00 RMB, with a net amount of 2,966,543,311.66 RMB after expenses[15]. - As of the end of the reporting period, 2,310,214,400 RMB (23,102,144 bonds) of the convertible bonds have been converted into 292,040,018 shares[15]. - The remaining amount of convertible bonds is 679,785,600 RMB, with 6,797,856 bonds left[15]. - The company has issued a total of 292,040,018 shares from the convertible bonds, with 26,974,600 shares coming from repurchased shares[15]. - The company’s stock is listed on the Shenzhen Stock Exchange under the bond name "Qixiang Convertible 2" with the code 128128[15]. Operational Changes - The company is in the process of a potential change in control, with PAGAC expressing intent to purchase all shares held by the controlling shareholder, despite ongoing judicial restrictions[16]. - The company has suspended the spin-off of its subsidiary, Shandong Qilu Keli Chemical Research Institute Co., Ltd., due to the impact of the controlling shareholder's equity transfer[16]. - The company has completed a comprehensive due diligence process with PAGAC and is cooperating on further documentation related to the share transfer[16]. Research and Development - Research and development expenses increased to ¥525,078,881.79 from ¥412,853,819.74, representing a rise of 27.2%[26].
齐翔腾达(002408) - 2022 Q2 - 季度财报
2022-08-28 16:00
Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the first half of 2022, representing a year-on-year growth of 20%[23]. - The company's operating revenue for the reporting period was ¥16,405,138,057.33, a decrease of 7.57% compared to the same period last year[28]. - The net profit attributable to shareholders was ¥901,049,381.12, down 38.66% year-on-year[28]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥891,019,039.46, a decrease of 38.53% compared to the previous year[28]. - The basic earnings per share decreased by 41.07% to ¥0.33, while diluted earnings per share fell by 41.51% to ¥0.31[28]. - The weighted average return on equity was 6.80%, down from 13.88% in the same period last year[28]. - Total operating revenue for the reporting period was ¥16,405,138,057.33, a decrease of 7.57% compared to ¥17,749,171,083.74 in the same period last year[64]. - Chemical manufacturing revenue increased by 26.62% to ¥9,260,470,164.84, accounting for 56.45% of total revenue[64]. - Supply chain management revenue decreased by 32.79% to ¥6,958,510,823.22, representing 42.42% of total revenue[64]. - Domestic revenue fell by 28.28% to ¥8,805,891,487.83, while international revenue rose by 38.91% to ¥7,599,246,569.50[64]. - The company reported a significant increase in other business revenue, which rose by 128.56% to ¥186,157,069.27[64]. Market Expansion and Product Development - User data showed an increase in active customers, with a total of 500,000 new users acquired in the first half of 2022, marking a 15% increase compared to the previous period[23]. - The company has set a future outlook with a revenue target of 3 billion RMB for the full year 2022, indicating a projected growth rate of 25%[23]. - New product development includes the launch of two innovative chemical products, expected to contribute an additional 200 million RMB in revenue by the end of 2022[23]. - The company is expanding its market presence, with plans to enter three new regional markets by Q4 2022, aiming for a 10% market share in each[23]. - The company has completed the construction of an 80,000 tons/year MEK expansion project, increasing its total design capacity to over 260,000 tons/year[41]. - The company plans to expand its maleic anhydride capacity by an additional 200,000 tons/year, aiming for a total capacity exceeding 400,000 tons/year[42]. - The company is also developing an 80,000 tons/year acrylic acid and a 60,000 tons/year butyl acrylate project, enhancing its product offerings in the acrylics market[46]. Strategic Acquisitions and Investments - A strategic acquisition of a smaller competitor was completed, valued at 500 million RMB, which is expected to enhance the company's production capacity by 30%[23]. - The company has invested 100 million RMB in R&D for new technologies, focusing on sustainable chemical processes, with expected completion by mid-2023[23]. - The company has invested in a 700,000 tons/year propane dehydrogenation project, which has been fully completed and operational[46]. - The company has established a comprehensive propane-propylene-epoxy propane/acrylic acid industrial chain layout, with new projects including a 700,000 tons/year propane dehydrogenation project and a 300,000 tons/year epoxy propane project[48]. - The company has invested in a 360 tons/year maleic anhydride catalyst project, which has been completed and is producing qualified products[42]. Operational Efficiency and Cost Management - The company has implemented new operational strategies aimed at reducing costs by 15% over the next year through efficiency improvements[23]. - The company has achieved a cost advantage through technological innovations and improved operational efficiency, reducing manufacturing costs[54]. - The company has a flexible production design that allows for adjustments in product structure based on market conditions, maximizing overall profitability[52]. Environmental Compliance and Sustainability - The company has established a comprehensive safety control system to mitigate risks associated with the production of flammable and corrosive chemical products[97]. - Environmental protection measures are in place to ensure compliance with regulations, and the company has invested in facilities for wastewater treatment and emissions control[98]. - The company has reported wastewater discharge parameters: COD at 20.8 mg/L, ammonia nitrogen at 0.243 mg/L, total phosphorus at 0.0393 mg/L, and total nitrogen at 7.13 mg/L, all meeting standards[110]. - The company achieved compliance in air emissions with sulfur dioxide at 3 mg/m³, nitrogen oxides at 60 mg/m³, and particulate matter at 1.95 mg/m³[110]. - The company has successfully maintained all emission standards across its operational facilities, demonstrating commitment to environmental responsibility[110]. Risk Management - The company has identified macroeconomic risks, including fluctuations in raw material prices, which could impact profit margins by up to 5%[7]. - The company faces macroeconomic risks due to ongoing global uncertainties, including the COVID-19 pandemic and geopolitical tensions, which may adversely affect industry development[92]. - Raw material costs account for over 50% of product costs, and fluctuations in international oil prices can significantly impact gross margins and operating performance[96]. Corporate Governance and Shareholder Relations - The company has committed to avoiding any substantial competition with its subsidiaries and ensuring independent operations post-acquisition of an 80% stake in Zibo Qixiang Petrochemical Group[162]. - The company has maintained a commitment to fair and reasonable pricing in related transactions to protect the interests of its shareholders[162]. - The controlling shareholder, Zibo Qixiang Petrochemical Group Co., Ltd., commits not to misuse company funds or require guarantees for debts from related enterprises, ensuring the protection of minority shareholders' interests[165]. - The company has a lock-up period of 36 months for shares held by major shareholders, with a maximum of 25% of shares allowed to be transferred annually during their tenure[165]. - The company has not made any securities or derivative investments during the reporting period[77][78]. Legal Matters - The company reached a settlement agreement with Shanghai Huayi Acrylic Co., agreeing to pay a total of 40 million yuan to resolve a commercial secret dispute, which was previously claimed at 50 million yuan[177]. - The company is currently involved in a lawsuit regarding a share transfer dispute, with a claim for compensation of 8.4 million yuan, which is still under court review[178].
齐翔腾达(002408) - 2020 Q4 - 年度财报
2022-05-20 16:00
Financial Performance - The company's operating revenue for 2020 was ¥24,685,919,355.10, a decrease of 17.87% compared to ¥30,057,692,948.62 in 2019[23]. - The net profit attributable to shareholders for 2020 was ¥975,715,572.45, an increase of 57.25% from ¥620,495,267.66 in 2019[23]. - The net cash flow from operating activities reached ¥1,387,410,358.86, representing an increase of 81.40% compared to ¥764,837,717.46 in 2019[23]. - The basic earnings per share for 2020 was ¥0.56, up 60.00% from ¥0.35 in 2019[23]. - Total assets at the end of 2020 amounted to ¥20,638,901,335.33, a growth of 46.06% from ¥14,130,817,063.18 at the end of 2019[23]. - The net assets attributable to shareholders increased by 18.79% to ¥8,981,031,961.94 at the end of 2020 from ¥7,560,364,636.57 at the end of 2019[23]. - The company reported a diluted earnings per share of ¥0.46 for 2020, which is a 31.43% increase from ¥0.35 in 2019[23]. - The weighted average return on equity for 2020 was 11.94%, an increase of 3.67% compared to 8.27% in 2019[23]. - The company achieved a total revenue of CNY 24.69 billion in 2020, a decrease of 17.87% year-on-year[54]. - The net profit attributable to shareholders increased by 57.25% year-on-year, reaching CNY 976 million[54]. - The total assets grew by 46.06% year-on-year, amounting to CNY 20.64 billion[54]. - The production volume of major chemical products reached 1.67 million tons, an increase of 2.61% year-on-year[54]. Dividend Distribution - The company plans to distribute a cash dividend of 2.86 CNY per 10 shares, totaling approximately 499,995,110.76 CNY before tax, based on a total share capital of 1,775,209,253 shares as of December 31, 2020[5]. - The cash dividend payout ratio for 2020 is 51.24% of the net profit attributable to ordinary shareholders, which is 975.72 million CNY[122]. - The total cash dividend, including other methods like share buybacks, for 2020 is 699.91 million CNY, representing 71.73% of the net profit[122]. - The total number of shares eligible for the 2020 cash dividend distribution is 1,748,234,653 shares after accounting for repurchased shares[125]. - The company has maintained compliance with its cash dividend policy, ensuring transparency and protection of minority shareholders' rights[119]. Risk Management - The company emphasizes the importance of risk awareness, highlighting macroeconomic fluctuations, environmental risks, safety production risks, operational risks, and exchange rate fluctuations as key challenges[4]. - The company is actively monitoring and addressing various operational risks to safeguard its business continuity and growth[4]. - The company faces risks from macroeconomic fluctuations, environmental regulations, and raw material price volatility, with strategies in place to mitigate these risks[109][111][113]. Research and Development - The company has outlined its commitment to research and development, focusing on new products and technologies to enhance market competitiveness[4]. - The company's research and development expenditure amounted to CNY 271,205,776.61, a decrease of 14.21% from the previous year, representing 1.10% of total operating revenue[74]. - The company reported a total of 293 R&D personnel, an increase of 3.90% from 2019[74]. Production Capacity and Projects - The company has invested in a 200,000 tons/year methyl methacrylate (MMA) project, enhancing its product line and economic benefits by converting low-value MTBE into high-value MMA[33]. - The company has upgraded its nitrile latex production capacity, resulting in significant improvements in both capacity and product quality, with a new 200,000 tons/year nitrile latex project now operational[33]. - The company is advancing its propane dehydrogenation and downstream epoxy propane projects, targeting a total capacity of 700,000 tons/year for propane dehydrogenation and 300,000 tons/year for epoxy propane[33]. - The company plans to build a new 200,000 tons/year maleic anhydride production capacity to meet the growing downstream demand[105]. - The company is investing in a 700,000 tons/year propane dehydrogenation and 300,000 tons/year propylene oxide project, expanding its business from C4 to C3[105]. - The company is focusing on high-value fine chemicals and new chemical materials, including biodegradable plastics and hydrogen energy[108]. Environmental Compliance - The company has implemented sustainable development practices, ensuring environmental protection is integrated into every production stage and continuously improving risk control measures[176]. - The company has achieved all emissions standards across its operations, demonstrating a commitment to environmental compliance[180]. - The company reported total emissions of sulfur dioxide at 12.4 tons and nitrogen oxides at 86 tons from its new boiler exhaust outlets, all within compliance limits[178]. - The wastewater discharge met standards with COD levels at 22.7 mg/L, ammonia nitrogen at 0.58 mg/L, and total nitrogen at 7.23 mg/L[178]. - The company has signed contracts for wastewater treatment, ensuring that discharge parameters remain within specified limits[180]. - The company has constructed two wastewater treatment facilities with a total capacity of 100 m³/h for anaerobic treatment and 30,000 tons/day for aerobic treatment[186]. Corporate Governance - The company has committed to avoiding any substantial competition with its subsidiaries and ensuring fair pricing in related transactions[129]. - The controlling shareholder guarantees that no funds will be misappropriated from the company for personal loans or debts, with a penalty of five times the bank loan interest rate for violations[130]. - The company has established related party transaction systems to ensure fair pricing and protect the interests of minority shareholders[135]. - The company has successfully fulfilled all commitments made regarding shareholding and related transactions[137]. Subsidiaries and Acquisitions - The company established Zibo Qixiang Tengda Chemical Sales Co., Ltd. to centralize raw material and product sales, improving decision-making efficiency and capital utilization, officially included in the consolidated financial statements from March 2020[145]. - The company acquired 100% equity of Zibo City Linzi District Petrochemical Fuel Co., Ltd. for 160.6527 million yuan, which became a wholly-owned subsidiary and was included in the consolidated financial statements from June 2020[145]. - The company founded Qixiang Tengda (Zibo) Medical Materials Co., Ltd. to expand into the medical materials sector, officially included in the consolidated financial statements from October 2020[145]. - The company established Zibo Qixiang Huali New Materials Co., Ltd. to enhance business integration, officially included in the consolidated financial statements from December 2020[145]. Employee Welfare - The company has established a comprehensive training system for over 2,000 employees across 26 categories, ensuring reasonable promotion opportunities[175]. - The company has implemented a labor safety and welfare system, conducting annual health checks for all production staff[174]. - The company emphasizes employee safety and health, providing protective tools for special job roles and investing in employee facilities, including canteens and dormitories[176].
齐翔腾达(002408) - 2021 Q4 - 年度财报
2022-04-28 16:00
Financial Performance - The company reported a total revenue of 2,842,662,614 CNY for the year 2021, with a profit distribution plan of 0.00 CNY per 10 shares [8]. - The company's operating revenue for 2021 was ¥34.89 billion, an increase of 41.34% compared to ¥24.69 billion in 2020 [28]. - The net profit attributable to shareholders for 2021 was ¥2.39 billion, representing a 145.22% increase from ¥975.72 million in 2020 [28]. - The net profit after deducting non-recurring gains and losses was ¥2.38 billion, up 143.95% from ¥976.18 million in 2020 [28]. - The net cash flow from operating activities reached ¥2.04 billion, a 47.07% increase from ¥1.39 billion in 2020 [28]. - The total assets at the end of 2021 were ¥26.07 billion, reflecting a 26.32% increase from ¥20.64 billion at the end of 2020 [28]. - The net assets attributable to shareholders at the end of 2021 were ¥12.79 billion, up 42.41% from ¥8.98 billion at the end of 2020 [28]. - The company reported a significant increase in basic earnings per share to ¥0.86, up 115% from ¥0.40 in 2020 [28]. - The weighted average return on equity for 2021 was 21.27%, an increase of 9.33% from 11.94% in 2020 [28]. - In 2021, the company achieved a total revenue of CNY 34.89 billion, a year-on-year increase of 41.34% [66]. - The net profit attributable to shareholders reached CNY 2.39 billion, representing a significant growth of 145.22% compared to the previous year [65]. - The total production volume of major chemical products was 2.14 million tons, an increase of 27.86% year-on-year [65]. - The company's total assets grew to CNY 26.07 billion, marking a 26.32% increase from the previous year [65]. - The gross profit margin for the chemical manufacturing segment was 25.85%, with a year-on-year increase of 3.80% [69]. Market Strategy and Expansion - The company is focused on expanding its market presence and has outlined future development strategies in the annual report [7]. - The company aims to expand its overseas business to alleviate domestic market pressure and enhance the synergy between its chemical and supply chain sectors [39]. - The company plans to focus on new energy and new materials in its fifth six-year plan, enhancing R&D collaboration with top domestic and international firms [39]. - The company is strategically positioned to capture market opportunities through enhanced coordination across production, supply, sales, and finance [43]. - The company plans to seek new solutions for raw material supply after terminating the construction of the Laizhou Port low-temperature storage tank project [73]. - The company is considering strategic acquisitions to enhance its market position, with a budget of 500 million RMB allocated for potential deals [158]. - Market expansion plans include entering two new international markets by Q3 2024 [158]. Risk Management - The company has detailed risks including macroeconomic fluctuations, environmental risks, safety production risks, operational risks, and exchange rate fluctuations in the annual report [7]. - The company emphasizes the importance of rational investment and risk awareness for its investors [7]. - The company has established a strict risk management system to address various operational and financial risks associated with the chemical industry [61]. - The company faces risks from macroeconomic fluctuations, industry competition, raw material price volatility, safety production, environmental protection, and exchange rate fluctuations, with strategies in place to mitigate these risks [116][117][118][120][121][122]. Research and Development - The company has committed to ensuring the accuracy and completeness of its financial reports, with key personnel affirming the integrity of the data presented [6]. - R&D expenses surged by 113.33% to ¥578,562,521.14, reflecting increased investment in new project development [77]. - The number of R&D personnel rose by 52.53% to 453, with the proportion of R&D personnel in the company increasing to 17.84% [80]. - R&D investment amounted to ¥578,562,521.14, representing 1.66% of operating revenue, up from 1.10% in 2020 [81]. - The company is committed to continuous R&D investment to advance into high-tech fields and enhance its overall risk resistance capabilities [56]. Production Capacity and Operations - The company maintains its primary business in the chemical manufacturing and supply chain management sectors, focusing on products such as acetone, butadiene, and various catalysts [40]. - Acetone, the company's flagship product, has a gross margin of 35.76% and holds approximately 50% of the domestic market share, with over 70% of the domestic export share [43]. - The company has invested in expanding its acetone production capacity by 80,000 tons/year, aiming to reach a total design capacity of 260,000 tons/year [46]. - The newly constructed 200,000 tons/year nitrile latex facility is currently the largest in China, significantly enhancing production quality and output [48]. - The company has established a 200,000 tons/year production capacity for maleic anhydride, becoming the world's largest producer, with plans to expand this capacity by an additional 200,000 tons/year [49]. - The catalyst business is expected to see steady growth due to increasing demand for sulfur recovery catalysts and hydrogen catalysts driven by downstream expansion [51]. - The new materials segment includes a 200,000 tons/year methyl methacrylate (MMA) project, which has significant growth potential due to rising demand in various applications [52]. - The company has optimized its carbon four utilization process, enhancing its product line and improving risk resistance through diversified product offerings [43]. - The company has invested in a 700,000 tons/year propane dehydrogenation project and a 300,000 tons/year propylene oxide project, which have been fully completed and put into production, enhancing its market share and profitability in the C3 industrial chain [53]. - The company is also constructing an 80,000 tons/year acrylic acid and a 60,000 tons/year butyl acrylate project, which will further integrate with the propane dehydrogenation project to maximize product efficiency [53]. Corporate Governance - The company has engaged in multiple investor communications throughout 2021, discussing financial data, operational changes, and new project developments [123]. - The company held 2 shareholder meetings during the reporting period, ensuring compliance with legal regulations and providing a platform for minority shareholders to participate effectively [129]. - The board of directors consists of 9 members, with 3 independent directors, meeting the legal requirements for board composition [130]. - The company conducted 12 board meetings during the reporting period, adhering to legal and procedural standards [130]. - The supervisory board comprises 3 members, ensuring oversight of major investments and financial decisions [131]. - The company maintains complete independence from its controlling shareholder, with no shared business operations or financial resources [138]. - The company has established a comprehensive performance evaluation system for directors and senior management, linking compensation to performance outcomes [135]. - The company operates independently in procurement, production, and sales, with no related party transactions affecting its operations [138]. - The company has a fully independent financial department, ensuring separate financial decision-making and compliance with tax regulations [141]. Employee and Shareholder Engagement - The company has implemented an employee stock ownership plan, with 335 employees holding a total of 79,662,841 shares, representing 2.80% of the total share capital [196]. - The total number of employees at the end of the reporting period was 3,255, with 2,741 holding a college degree or above [181]. - The company has maintained a stable board of directors with no significant changes in personnel during the reporting period [145]. - The company has not proposed any suggestions that were not adopted during the reporting period [174]. Compliance and Internal Controls - The company emphasizes strict adherence to relevant laws and regulations regarding profit distribution and internal control systems [195]. - The company has a comprehensive internal control system that includes oversight by the audit committee and internal audit department [200]. - The internal control self-evaluation report was disclosed on April 29, 2022 [200]. - The evaluation criteria for defects include compliance with national laws and regulations, as well as the effectiveness of decision-making processes [200]. - The company aims to rectify identified defects within a reasonable timeframe to maintain effective internal controls [200].
齐翔腾达(002408) - 2022 Q1 - 季度财报
2022-04-28 16:00
淄博齐翔腾达化工股份有限公司 2022 年第一季度报告全文 债券代码:128128 债券简称:齐翔转 2 淄博齐翔腾达化工股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在 虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告 中财务信息的真实、准确、完整。 3、公司第一季度报告未经过审计。 一、主要财务数据 (一)主要会计数据和财务指标 1 证券代码:002408 证券简称:齐翔腾达 公告编号:2022-048 | --- | --- | --- | --- | |-----------------------------------------------------|-------------------|-------------------|---------------------------| | | 本报告期 | 上年 ...
齐翔腾达(002408) - 2021 Q3 - 季度财报
2021-10-27 16:00
Financial Performance - The company's operating revenue for Q3 2021 reached ¥8,006,369,940.49, representing a 24.68% increase year-over-year[3] - Net profit attributable to shareholders was ¥693,970,631.71, a significant increase of 122.79% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was ¥671,120,533.63, up 131.49% year-over-year[3] - The company's operating revenue for Q3 2021 reached ¥25.76 billion, a 57.69% increase from ¥16.33 billion in the same period last year[6] - Net profit for the period was ¥2,237,608,219.98, compared to ¥837,907,074.56 in the same period last year, reflecting a growth of approximately 167.5%[25] - Earnings per share (basic) rose to ¥0.81, compared to ¥0.32 in the previous year, indicating a growth of 153.1%[26] - The company reported a total comprehensive income of ¥2,235,265,553.71, up from ¥832,721,241.48, representing a growth of approximately 168.8% year-over-year[26] Assets and Liabilities - Total assets as of September 30, 2021, amounted to ¥25,091,295,414.38, reflecting a 21.57% increase from the end of the previous year[3] - The company's equity attributable to shareholders increased to ¥12,454,677,991.06, a rise of 38.68% compared to the end of last year[3] - The company's total assets increased to CNY 25,091,295,414.38 as of September 30, 2021, up from CNY 20,638,901,335.33 at the end of 2020, representing a growth of approximately 21.8%[21] - The company's total liabilities as of September 30, 2021, amounted to CNY 8,358,031,874.53, compared to CNY 7,636,369,120.40 at the end of 2020, an increase of about 9.5%[21] - The total liabilities stood at ¥11,758,942,535.14, compared to ¥10,853,860,320.90, reflecting an increase of approximately 8.3%[24] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥1,523,775,992.67, showing a 117.52% increase year-over-year[3] - The net cash flow from operating activities was ¥1.52 billion, a 117.52% increase from ¥700.51 million, attributed to higher profits from new and existing products[6] - The net cash flow from operating activities for Q3 2021 was CNY 1,523,775,992.67, an increase of 117.0% compared to CNY 700,512,121.22 in the same period last year[28] - Total cash inflow from operating activities reached CNY 25,996,353,360.49, up from CNY 18,849,002,019.91, representing a growth of 37.4%[28] - Cash outflow for purchasing goods and services was CNY 22,605,749,748.73, compared to CNY 16,383,699,592.92, marking a 38.0% increase[28] - The net cash flow from investment activities was CNY -2,156,554,445.54, an improvement from CNY -2,790,226,506.40 year-over-year[30] Investments and Expenses - R&D expenses surged by 93.33% to ¥412.85 million, compared to ¥213.55 million, reflecting increased investment in new projects[6] - Long-term equity investments increased by 107.40% to ¥167,269,112.37, reflecting new investments in Tianchen Qixiang and WE Chem International GmbH[5] - Investment income rose significantly by 206.86% to ¥18.65 million, up from ¥6.08 million, driven by returns from bank wealth management products and long-term equity investments[6] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 65,640[9] - The largest shareholder, Zibo Qixiang Petrochemical Group Co., Ltd., holds 46.47% of the shares, totaling 1,305,214,885 shares[9] Other Information - The company is in the process of splitting its subsidiary, Shandong Qilu Keli Chemical Research Institute Co., Ltd., for listing on the Growth Enterprise Market, with the counseling record accepted by the Shandong Securities Regulatory Bureau on July 22, 2021[19] - The company is involved in ongoing litigation regarding trade secret infringement, with claims for damages amounting to CNY 50 million[15] - The third quarter report has not been audited[36] - The report was released by the board of directors on October 28, 2021[37]
齐翔腾达(002408) - 2021 Q2 - 季度财报
2021-08-30 16:00
Financial Performance - The company's operating revenue for the reporting period reached ¥17,749,171,083.74, representing a 79.08% increase compared to the same period last year [23]. - Net profit attributable to shareholders was ¥1,468,823,846.10, marking a significant increase of 208.93% year-over-year [23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥1,449,576,421.83, up 228.55% from the previous year [23]. - The net cash flow from operating activities was ¥1,046,351,158.78, an increase of 168.79% compared to the same period last year [25]. - Basic earnings per share rose to ¥0.78, reflecting an increase of 188.89% year-over-year [25]. - Total assets at the end of the reporting period amounted to ¥23,511,593,005.69, a 13.92% increase from the end of the previous year [25]. - The net assets attributable to shareholders reached ¥11,687,004,778.26, which is a 30.13% increase compared to the previous year [25]. - The company's operating revenue for the first half of 2021 reached ¥17.75 billion, a 79.08% increase compared to ¥9.91 billion in the same period last year, driven by new capacity release, rising product prices, and increased supply chain business volume [47]. - The operating cost increased by 72.34% to ¥15.29 billion, up from ¥8.87 billion, attributed to new project launches and rising raw material prices [47]. Investment and Expansion - The company plans to invest in expanding its MIBK production capacity by 80,000 tons/year, increasing total capacity to 260,000 tons/year [36]. - The company aims to expand its maleic anhydride capacity by an additional 200,000 tons/year, bringing total capacity to 400,000 tons/year [38]. - The company has initiated a 200,000 tons/year methyl methacrylate (MMA) project, which is crucial for the production of high-end display screens and other applications [40]. - The company plans to invest in expanding its 200,000 tons/year maleic anhydride project to meet increasing market demand [128]. - The company has ongoing major non-equity investments, including a 70,000 tons/year propane dehydrogenation project with an investment of ¥317,444,452.12 [59]. Supply Chain Management - The company continues to focus on the chemical manufacturing sector and supply chain management, with a diverse product line including various chemical products [33]. - The supply chain management segment has shown good development, optimizing product and customer structures to enhance profitability [33]. - The supply chain management segment has successfully acquired 49% of Granite Capital S.A., enhancing the company's market position in the chemical supply chain [41]. - The supply chain management business accounted for 58.33% of total operating revenue, amounting to ¥10.35 billion, with a year-on-year increase of 75.10% [49]. - The domestic market contributed 69.18% of total revenue, amounting to ¥12.28 billion, while the international market contributed 30.82%, totaling ¥5.47 billion, reflecting a year-on-year growth of 44.38% [49]. Risk Management - The company emphasizes the importance of risk awareness, including macroeconomic fluctuations, environmental risks, safety production risks, operational risks, and exchange rate fluctuations [5]. - The company has implemented a strict risk control management system to mitigate various operational and financial risks associated with the chemical industry [45]. - The company faces macroeconomic risks due to the ongoing global COVID-19 pandemic, which may adversely affect industry development [64]. - Raw materials account for over 50% of the company's product costs, and fluctuations in raw material prices could negatively impact gross margins and operating performance [66]. Environmental Compliance - The company adheres to strict environmental regulations and has implemented effective waste management practices to meet environmental standards [68]. - The company reported a total emission of 625.02276 tons of sulfur dioxide and 1242.21 tons of nitrogen oxides, all emissions met the standards [78]. - Wastewater discharge included COD at 20.1 mg/L, ammonia nitrogen at 0.59 mg/L, total phosphorus at 0.0483 mg/L, and total nitrogen at 6.87 mg/L, all within regulatory limits [79]. - The company has established a comprehensive monitoring system to ensure all emissions remain within regulatory limits [78]. - The company has implemented a comprehensive pollution prevention and control strategy, ensuring all facilities are operating effectively [83]. Corporate Governance - The company has committed to avoiding any substantial competition with Qichuang Tengda and its subsidiaries after acquiring 80% of Zibo Qichuang Petrochemical Group Co., Ltd. [100]. - The controlling shareholder has pledged not to misuse company funds or request guarantees for debts of related enterprises, with legal consequences for violations [101]. - The company will not engage in any business that competes with Qichuang Tengda's chemical supply chain operations, both currently and in the future [101]. - The company has established a long-term commitment to uphold its promises regarding competition and related transactions [100]. - The company reported no non-operating fund occupation by controlling shareholders or other related parties during the reporting period [105]. Legal Matters - The company faced a lawsuit from Shanghai Huayi Acrylic Acid Co., claiming economic damages of 50 million yuan due to trade secret infringement, which was later withdrawn and refiled for 365,700 yuan per case [108]. - Tianjin Youshan Chemical Co. sued the company for 68.1669 million yuan in economic losses, but the court ruled in favor of the company, maintaining the original judgment [108]. - The company has ongoing litigation matters, with a court hearing scheduled for September 10, 2021, regarding the trade secret case [108]. - The company continues to monitor and manage its legal and financial obligations related to ongoing litigation and related party transactions [108]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 49,299 [143]. - Zibo Qixiang Tengda Chemical Co., Ltd. held 46.71% of shares, totaling 932,296,347 shares, with an increase of 88,004,846 shares during the reporting period [177]. - The company’s chairman, Che Chengju, increased his holdings by 11,454,902 shares, bringing his total to 66,512,379 shares [178]. - The company does not have any preferred shares outstanding during the reporting period [181]. - The company has not engaged in any repurchase transactions during the reporting period [177].
齐翔腾达(002408) - 2021 Q1 - 季度财报
2021-04-29 16:00
淄博齐翔腾达化工股份有限公司 2021 年第一季度报告全文 淄博齐翔腾达化工股份有限公司 2021 年第一季度报告 2021 年 04 月 1 淄博齐翔腾达化工股份有限公司 2021 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人车成聚、主管会计工作负责人黄磊及会计机构负责人(会计主管 人员)荣芳声明:保证季度报告中财务报表的真实、准确、完整。 2 淄博齐翔腾达化工股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 | --- | --- | --- | --- | --- | |-----------------------------------------------------|-------------------|-------|-------------------|---------------------------| | | 本报告期 | | 上年同 ...